NewsCoronavirus

Actions

Company's $2,340 price for coronavirus drug draws criticism

1st results in on Gilead coronavirus drug; more study needed
Posted at 1:55 PM, Jun 29, 2020
and last updated 2020-06-29 13:55:32-04

The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients said it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.

Gilead Sciences announced the price Monday for remdesivir, and said the price would be $3,120 for patients with private insurance.

It will sell for far less in poorer countries where generic drugmakers are being allowed to make it.

Critics swiftly attacked the price because taxpayers have funded much of the drug's development, and because remdesivir has not been shown to improve survival.